Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
APA is holding its gains into November earnings with short sellers nudging positions back up, but the broader picture remains one of a contested stock in a sector-wide rally rather than a deteriorating bear case.
The shift since last week's note is modest but worth marking. Short interest has edged higher, now at 7.3% of free float, up roughly 5% across the week from 24.6 million shares to 25.8 million. That partially reverses the month-long decline documented a week ago, when positions had fallen to around 24.6 million. The directional story has shifted back toward rebuilding, not dramatically, but enough to register. The lending market tells a different tale entirely. Availability has tightened slightly from around 894% last week to 828% now, still meaning there are more than eight shares available to borrow for every one already lent out. Borrowing costs at 0.54% are trivially low. There is no squeeze pressure here, and no sign the new short interest is running into a constrained borrow pool. Options positioning remains call-leaning: the put/call ratio at 0.51 is fractionally below its 20-day average of 0.53, and the z-score of minus 0.77 keeps this firmly in unremarkable territory.
The Street has been constructive this week. Wells Fargo and UBS both raised price targets, Wells Fargo to $51 and UBS to $52, while maintaining cautious hold-equivalent ratings. Truist also lifted its target slightly to $45. The pattern is consistent across multiple banks: targets are moving up, but conviction ratings are not following. The mean price target across the analyst pool is now $46.92, fractionally above the current price of $48.01, which actually puts APA trading through the Street average. Raymond James, the clearest bull on the register, holds an Outperform with a $54 target. The value argument is not stretched: the stock trades at roughly 9.6 times earnings and 3.8 times EV/EBITDA. The EV/EBIT factor scores in the 84th percentile relative to the broader market. The forward earnings picture is more cautious, though, with the 12-month forward EPS growth factor ranking in the 28th percentile, reflecting limited expectations for near-term profit acceleration.
APA's performance this week broadly matched its peer group rather than standing out. COP rose 8.9% and PR gained 8.5%, both marginally ahead of APA's 8.9% weekly move, while OXY and DVN gained around 5.7% and 4.6% respectively. The sector is lifting the whole fleet. APA's slight short interest rebuild in the context of a strong weekly gain is consistent with some holders treating the rally as a shorting opportunity rather than a signal to cover.
Institutional ownership is concentrated and broadly stable. BlackRock added just over 2.2 million shares in the most recently reported period, pushing its stake to 10.6%. Geode added around 2.3 million shares. Hotchkis and Wiley, the second-largest holder at 9.3%, trimmed marginally. No 13D activist filings are on the register. Insider activity at the end of September consisted entirely of stock grants to board members, none carrying price data or discretionary intent, so nothing there changes the picture.
The next earnings release is scheduled for 5 November. That print is now three weeks away, which is the most relevant near-term event to watch, particularly given that the last Q2 release produced a 8.6% one-day move and a 15.4% five-day move. Whether the short interest rebuild continues into that date, or whether the analyst target-raising cycle eventually pulls ratings up to match the upgraded price targets, are the two threads worth tracking over the coming sessions.
See the live data behind this article on ORTEX.
Open APA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
